283 related articles for article (PubMed ID: 32576651)
21. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
[TBL] [Abstract][Full Text] [Related]
22. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.
Bozzella MJ; Chaney H; Sami I; Koumbourlis A; Bost JE; Zemanick ET; Freishtat RJ; Crandall KA; Hahn A
Pediatr Infect Dis J; 2021 Nov; 40(11):962-968. PubMed ID: 34269323
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.
Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR
PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403
[TBL] [Abstract][Full Text] [Related]
24. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
[TBL] [Abstract][Full Text] [Related]
25. The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi.
de Almeida OGG; Capizzani CPDC; Tonani L; Grizante Barião PH; da Cunha AF; De Martinis ECP; Torres LAGMM; von Zeska Kress MR
Front Cell Infect Microbiol; 2020; 10():598938. PubMed ID: 33262957
[TBL] [Abstract][Full Text] [Related]
26. Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics.
McDermott G; Walsh A; Crispie F; Frost S; Greally P; Cotter PD; O'Sullivan O; Renwick J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612702
[TBL] [Abstract][Full Text] [Related]
27. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.
Quinn RA; Whiteson K; Lim YW; Salamon P; Bailey B; Mienardi S; Sanchez SE; Blake D; Conrad D; Rohwer F
ISME J; 2015 Mar; 9(4):1024-38. PubMed ID: 25514533
[TBL] [Abstract][Full Text] [Related]
28. A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis.
Metzger MI; Graeber SY; Stahl M; Sommerburg O; Mall MA; Dalpke AH; Boutin S
Front Cell Infect Microbiol; 2021; 11():763121. PubMed ID: 34938669
[TBL] [Abstract][Full Text] [Related]
29. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation.
Carmody LA; Zhao J; Kalikin LM; LeBar W; Simon RH; Venkataraman A; Schmidt TM; Abdo Z; Schloss PD; LiPuma JJ
Microbiome; 2015; 3():12. PubMed ID: 25834733
[TBL] [Abstract][Full Text] [Related]
30. Multi-Omics Study of Keystone Species in a Cystic Fibrosis Microbiome.
Silveira CB; Cobián-Güemes AG; Uranga C; Baker JL; Edlund A; Rohwer F; Conrad D
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769481
[TBL] [Abstract][Full Text] [Related]
31. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
32. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
33. Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity.
Hahn A; Bendall ML; Gibson KM; Chaney H; Sami I; Perez GF; Koumbourlis AC; McCaffrey TA; Freishtat RJ; Crandall KA
Front Microbiol; 2018; 9():1069. PubMed ID: 29887843
[TBL] [Abstract][Full Text] [Related]
34. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics.
Smith DJ; Badrick AC; Zakrzewski M; Krause L; Bell SC; Anderson GJ; Reid DW
Eur Respir J; 2014 Oct; 44(4):922-30. PubMed ID: 25034564
[TBL] [Abstract][Full Text] [Related]
35. Anaerobes in cystic fibrosis patients' airways.
Lamoureux C; Guilloux CA; Beauruelle C; Jolivet-Gougeon A; Héry-Arnaud G
Crit Rev Microbiol; 2019 Feb; 45(1):103-117. PubMed ID: 30663924
[TBL] [Abstract][Full Text] [Related]
36. Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients.
Huang Q; Wang Y; Xia Y; Li L; Luo J; Xia S; Sun Y; Miao Y; Wang K; Chen Y
Medicine (Baltimore); 2018 Sep; 97(37):e12248. PubMed ID: 30212959
[TBL] [Abstract][Full Text] [Related]
37. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2015 Nov; (11):CD006961. PubMed ID: 26522473
[TBL] [Abstract][Full Text] [Related]
38. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
39. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
40. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.
Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR
J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
